[ Price : $8.95]
FDAs Minneapolis District Office warns Nemschoff Chairs about Medical Device Reporting violations involving its Serenity patient c...[ Price : $8.95]
FDA extends by three months its review of a Novartis NDA for LBH589 (panobinostat) for use in combination with bortezomib and dexa...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Avena Botancials, Bodyhealth.com, Ebola-C Inc., Excelsior Medical, Navilyst Medi...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Product Labeling for Laparoscopic Power Morcellators.[ Price : $8.95]
FDAs New York District Office warns Navilyst Medical about Quality System violations at two facilities that are specification deve...[ Price : $8.95]
FDA issues a drug safety alert on Biogen Idecs new multiple sclerosis drug Tecfidera (dimethyl fumarate) after the company confirm...[ Price : $8.95]
A new IMS Health reports says that global drug spending is forecast to grow at a 4-7% compound annual rate over the next five year...[ Price : $8.95]
The Generic Pharmaceutical Association and other commenters say an FDA proposal to refuse to receive an ANDA due to lack of justif...